Kevin C. Nash - Feb 1, 2023 Form 4 Insider Report for GENTEX CORP (GNTX)

Role
Chief Financial Officer
Signature
/s/ Scott Ryan for Kevin C. Nash by Power of Attorney
Stock symbol
GNTX
Transactions as of
Feb 1, 2023
Transactions value $
-$99,765
Form type
4
Date filed
2/2/2023, 09:12 AM
Previous filing
Feb 23, 2022
Next filing
Feb 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNTX Common Stock Options Exercise $99.6K +6.78K +31.18% $14.70 28.5K Feb 1, 2023 Direct
transaction GNTX Common Stock Sale -$199K -6.78K -23.07% $29.42 22.6K Feb 1, 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GNTX Employee Stock Option (Right to buy) Options Exercise $0 -6.78K -100% $0.00* 0 Feb 1, 2023 Common Stock 6.78K $14.70 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $29.32 to $29.56. The price reported above reflects the weighted average price.
F3 Column 5 reflects the acquisition of 865 shares under the Gentex Corp. Employee Stock Purchase Plan.
F4 These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date.